Where does Heartsine Technologies Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Heartsine Technologies Limited ranks #16,075 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Heartsine Technologies Limited hold?

Heartsine Technologies Limited holds 18 US utility patents granted between 2015 and 2024, spanning 6 technology areas.

What is Heartsine Technologies Limited's Innovation Score?

Heartsine Technologies Limited has an Innovation Score of 48.5 out of 100 (top 17% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Heartsine Technologies Limited focus on?

Heartsine Technologies Limited's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 17 patents, ranking #211 of 1,943 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Heartsine Technologies Limited's patent grant rate increasing or decreasing?

Heartsine Technologies Limited's recent grant velocity is -20% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Heartsine Technologies Limited's patents?

Heartsine Technologies Limited's patents average 16.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Heartsine Technologies Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Heartsine Technologies Limited

USPTO PatentsView assignee record - 18 granted patents across 6 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Heartsine ranks #16,075 of 49,997 tracked US assignees by granted-patent volume, with 18 patents across 6 technology areas.

#16,075
of 49,997 US assignees by volume: Top 17%
by Innovation Score (48.5/100): 16.1
avg claims per patent: -20%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16075 · Foreign Corporation #16,075 · 18 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 18 grants
MID-PACK #16,075/49,997
PHOTO-FINISH H4 Engineering
CPC-NARROW A61N · 6 areas
INNOV-PAR 48.5/100
CLAIMS-RICH 16.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -20% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: H4 Engineering, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Heartsine’s 48.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.2 pts (21%) Velocity 20.0 pts (41%) Breadth 8.7 pts (18%) Claim depth 9.6 pts (20%)

Qualcomm Incorporated · highest

85
Heartsine · this assignee

48
3D Lighting… · lowest

7

What this shows Heartsine's Innovation Score is 48.5/100 (top 17% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Heartsine?

Each dot is one of Heartsine’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Heartsine’s own 16.1 claims/patent is ABOVE the 14.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Heartsine vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Heartsine's grants concentrate

Heartsine Technologies Limited is a focused PatentsView assignee: 6 CPC subclasses with 94.4% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2015. By volume, Heartsine sits between H4 Engineering, Inc. and Horizon Orphan LLC.

Heartsine's three-year grant acceleration

Heartsine Technologies Limited shows 8 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

H4 Engineering

18
Haptech

18
Hbpo

18
HDT Expeditionary…

18
Hefei Midea Heati…

18
Highcon Systems

18
Hilverda Kooij B V

18
Horizon Orphan

18
Heartsine ◀

18

What this shows Heartsine holds 18 patents at rank #16,071, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Heartsine

By rank, the assignees closest to #16,071 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Heartsine's primary technology class.

Heartsine's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

48 Top 17% higher than 83% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Heartsine Technologies Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	5.6%
2016	3	16.7%
2017	4	22.2%
2018	1	5.6%
2019	1	5.6%
2022	2	11.1%
2023	2	11.1%
2024	4	22.2%

Which technologies does Heartsine Technologies Limited patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 17

A61B - DIAGNOSIS; SURGERY; Identification 8

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 4

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 3

G06F - Electric Digital Data Processing 3

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Heartsine Technologies Limited's patent record in context - here's where to go next.

Heartsine Technologies Limited's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 94.4% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #16,075 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Heartsine Technologies Limited against H4 Engineering, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 48.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.